CME Cme Group Inc

Price (delayed)

$182.18

Market cap

$65.48B

P/E Ratio

22.6

Dividend/share

$3.9

EPS

$8.06

Enterprise value

$205.47B

CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, ...

Highlights
The company's net income has surged by 52% YoY and by 5% QoQ
The EPS has surged by 51% year-on-year and by 5% since the previous quarter

Key stats

What are the main financial stats of CME
Market
Shares outstanding
359.43M
Market cap
$65.48B
Enterprise value
$205.47B
Valuations
Price to earnings (P/E)
22.6
Price to book (P/B)
2.34
Price to sales (P/S)
13.5
EV/EBIT
53.45
EV/EBITDA
48.72
EV/Sales
42.44
Earnings
Revenue
$4.84B
EBIT
$3.84B
EBITDA
$4.22B
Free cash flow
$2.66B
Per share
EPS
$8.06
Free cash flow per share
$7.4
Book value per share
$77.91
Revenue per share
$13.5
TBVPS
$406.06
Balance sheet
Total assets
$176.67B
Total liabilities
$148.67B
Debt
$141.87B
Equity
$28B
Working capital
$2.45B
Liquidity
Debt to equity
5.07
Current ratio
1.02
Quick ratio
1.01
Net debt/EBITDA
33.19
Margins
EBITDA margin
87.1%
Gross margin
100%
Net margin
60.4%
Operating margin
59%
Efficiency
Return on assets
1.5%
Return on equity
10.5%
Return on invested capital
2.4%
Return on capital employed
10.2%
Return on sales
79.4%
Dividend
Dividend yield
2.14%
DPS
$3.9
Payout ratio
48.4%

CME stock price

How has the Cme Group stock price performed over time
Intraday
2.24%
1 week
3.36%
1 month
-6.43%
1 year
-6.44%
YTD
-20.26%
QTD
2.85%

Financial performance

How have Cme Group's revenue and profit performed over time
Revenue
$4.84B
Gross profit
$4.84B
Operating income
$2.85B
Net income
$2.93B
Gross margin
100%
Net margin
60.4%
The company's net income has surged by 52% YoY and by 5% QoQ
The net margin has grown by 45% year-on-year and by 4.1% since the previous quarter
The operating income is up by 17% YoY and by 2.7% QoQ
Cme Group's operating margin has increased by 12% YoY

Growth

What is Cme Group's growth rate over time

Valuation

What is Cme Group stock price valuation
P/E
22.6
P/B
2.34
P/S
13.5
EV/EBIT
53.45
EV/EBITDA
48.72
EV/Sales
42.44
The EPS has surged by 51% year-on-year and by 5% since the previous quarter
CME's P/E is 24% below its last 4 quarters average of 29.1 and 20% below its 5-year quarterly average of 27.7
CME's price to book (P/B) is 18% lower than its last 4 quarters average of 2.8 and 12% lower than its 5-year quarterly average of 2.6
The equity has grown by 4.6% year-on-year
The P/S is 19% lower than the last 4 quarters average of 16.3 and 9% lower than the 5-year quarterly average of 14.5
CME's revenue is up by 5% year-on-year

Efficiency

How efficient is Cme Group business performance
Cme Group's return on equity has increased by 46% YoY and by 4% QoQ
The return on sales is up by 35% year-on-year and by 2.5% since the previous quarter
Cme Group's return on assets has increased by 15% YoY and by 7% QoQ
The ROIC has grown by 4.3% from the previous quarter and by 4.3% YoY

Dividends

What is CME's dividend history
DPS
$3.9
Dividend yield
2.14%
Payout ratio
48.4%
Recent dividends

Financial health

How did Cme Group financials performed over time
Cme Group's total assets is 19% more than its total liabilities
Cme Group's total liabilities has decreased by 17% QoQ and by 2.1% YoY
Cme Group's total assets has decreased by 14% from the previous quarter
The debt to equity has contracted by 18% from the previous quarter and by 6% YoY
The debt has declined by 17% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.